Industries

Life Sciences

Breakthroughs happen with Cooley

Advancing life sciences through unrivaled experience and industry relationships. With Cooley as your catalyst, you’re not just part of the life sciences industry – you’re shaping it.

Why Cooley

  • Unmatched industry experience

    Since incorporating the first-ever biotech company, Genentech, in 1976, Cooley has remained at the forefront of life sciences

  • Support across the full life cycle

    We represent innovative companies at every stage – from disruptive startups to global public companies across the biotech, pharmaceutical, medtech, diagnostics and digital health services industries

  • Market-leading deal volume

    We consistently lead in life sciences venture financings, initial public offerings (IPOs) and M&A, advising on hundreds of deals annually and helping our clients raise billions in capital

  • Legal partner to industry innovators

    Life sciences companies of all sizes turn to Cooley for strategic legal counsel that fuels innovation, supports growth and drives long-term success

Read more

Practices

  • 2,500+
    public and private life sciences and healthcare company clients worldwide
    500+
    timekeepers that devote half or more of their billable hours to life sciences clients
    #1
    for healthcare and life sciences initial public offerings since 2016 – Deal Point Data
    #1
    firm for pharma and biotech VC deals – PitchBook Annual Global League Tables, FY 2025
    #1
    in life sciences M&A by deal count in the US and globally – Bloomberg, H1 2025
    40+
    dedicated international professionals across the US, Europe and Asia exclusively focused on life sciences commercial transactions
    Tier 1
    for Corporate, Licensing & Collaboration, Venture Capital, Mergers & Acquisitions, Patent Strategy & Management, and Patent Prosecution – LMG Life Sciences Americas
    Read more
2,500+
public and private life sciences and healthcare company clients worldwide
500+
timekeepers that devote half or more of their billable hours to life sciences clients
#1
for healthcare and life sciences initial public offerings since 2016 – Deal Point Data
#1
firm for pharma and biotech VC deals – PitchBook Annual Global League Tables, FY 2025
#1
in life sciences M&A by deal count in the US and globally – Bloomberg, H1 2025
40+
dedicated international professionals across the US, Europe and Asia exclusively focused on life sciences commercial transactions
Tier 1
for Corporate, Licensing & Collaboration, Venture Capital, Mergers & Acquisitions, Patent Strategy & Management, and Patent Prosecution – LMG Life Sciences Americas
Read more

Cooley Talks Life Sciences

In this virtual series, we tap into Cooley’s unrivaled network of life sciences thought leaders to discuss key developments and challenges in the industry and share innovative solutions and perspectives to help companies shape their business strategy and navigate the future.

According to industry peers, the licensing, tax and inversion, private investment, capital market and M&A work performed by Cooley is top tier.

LMG Life Sciences

Recognitions

  • Chambers USA: Band 1 for Life Sciences (Nationwide, California, Massachusetts)
  • Chambers UK: Band 1 for Life Sciences: Transactional
  • The Legal 500 US: Tier 1 for Healthcare – Life Sciences
  • Law360: Life Sciences Practice Group of the Year (2022 – 2025)
  • LMG Life Sciences Americas: Tier 1 in Corporate, Venture Capital, Licensing & Collaboration, Mergers & Acquisitions, Patent Strategy and Patent Prosecution
  • LMG Life Sciences Americas: Corporate Firm of the Year (2023 – 2025)
  • LMG Life Sciences Americas: Hatch-Waxman Litigation Firm of the Year (2025)
  • LMG Life Sciences EMEA: Licensing and Collaboration Firm of the Year (2025)
  • PitchBook: #1 firm for pharma and biotech VC deals by deal count (2025)
  • Bloomberg: #1 for US and global life sciences M&A by deal count (H1 2025)

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as "Cooley"). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction, and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. When advising companies, our attorney-client relationship is with the company, not with any individual. This content may have been generated with the assistance of artificial intelligence (Al) in accordance with our Al Principles, may be considered Attorney Advertising and is subject to our legal notices.